Influence of 4-pyridone-3-carboxamide-1Β-D-ribonucleoside (4PYR) on activities of extracellular enzymes in endothelial human cells

• Published in: Nucleosides, nucleotides & nucleic acids Vol. 35; no. 10-12; pp. 732 - 736
• Main Authors: Pelikant-Małecka, I., Sielicka, A., Kaniewska, E., Smoleński, R. T., Słomińska, E. M.
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.12.2016
• Subjects: 4-Pyridone-3-carboxamide-1β-d-ribonucleoside (4PYR); 5'-Nucleotidase - metabolism; Adenosine Triphosphate - metabolism; Antigens, CD - metabolism; Apyrase - metabolism; Cell Line; endothelial cells; Endothelial Cells - drug effects; Endothelial Cells - enzymology; extracellular enzymes; GPI-Linked Proteins - metabolism; HMEC-1 cells; Humans; Nucleosides - pharmacology; Pyridones - pharmacology; HMEC-1 cells; 4-Pyridone-3-carboxamide-1β-d-ribonucleoside (4PYR); endothelial cells; extracellular enzymes
• ISSN: 1525-7770; 1532-2335
• DOI: 10.1080/15257770.2016.1174263

Previous studies demonstrated that human endothelial cells were capable to phosphorylate 4-pyridone-3-carboxamide-1β-D-ribonucleoside (4PYR) to monophosphate (4PYMP) and formed another metabolite-an analog of NAD (4PYRAD). Elevated levels of 4PYMP and 4PYRAD had an adverse effect on energy balance-depressed adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide (NAD) concentration in human endothelial cells. Ecto-enzymes such as ecto-nucleoside triphosphate diphosphohydrolase (eNTPD); ecto-5′-nucleotidase (e5'NT); and ecto-adenosine deaminase (eADA) are involved in controlling of inflammation and platelet aggregation. This study aimed to evaluate influence of 4PYR and its metabolites on activities of extracellular enzymes in human endothelial cells. Endothelial cells (endothelial cell line HMEC-1) were treated with 100 uM 4PYR for 0, 24, 48, or 72 hours. After incubation, intact HMEC-1 cells were incubated with suitable substrate. Simultaneously, in another path of experiments intracellular concentration of 4PYMP and 4PYRAD had been analyzed. Conversion of extracellular nucleotides into their products and intracellular concentration of 4PYMP and 4PYRAD were measured by high performance liquid chromatography (HPLC). We demonstrated that eNTPD and e5'NT activities increase after 72 hours of cell treatment with 4PYR as compared to control (0.40 ± 0.02 versus 0.29 ± 0.02 nmol/min/mg protein; 13.3 ± 0.6 versus 8.30 ± 0.34 nmol/min/mg protein, respectively, mean ± SEM). eADA activity decreases after 24 hours of cells treatment with 4PYR as compared to control (1.55 ± 0.06 versus 1.92 ± 0.13 nmol/min/mg protein, respectively, mean ± SEM). 4PYR and its derivatives have positive effect on ecto-enzymes related with ATP degradation pathway. We conclude that these increases in extracellular enzyme activities are an adaptive response to decreased intracellular ATP and NAD arising from 4PYR uptake. These changes may protect the cells from the inflammatory result of external ATP degradation.